Trends in Medication Treatment for ADHD

Overview

Journal J Atten Disord

Publisher Sage Publications

Specialty Psychiatry

Date 2007 Apr 24

PMID 17449832

Citations 74

Authors

Lon Castle

Ronald E Aubert

Robert R Verbrugge

Mona Khalid

Robert S Epstein

Affiliations

Soon will be listed here.

Abstract

Objective: This study examines demographic trends in the use of medications to treat ADHD in adult and pediatric populations.

Method: Using pharmacy claims data for a large population of commercially insured Americans, the study measures ADHD treatment prevalence and drug use from 2000 to 2005.

Results: In 2005, 4.4% of children (ages 0 to 19) and 0.8% of adults (ages 20 and older) used ADHD medications. Treatment rates were higher in boys (6.1%) than in girls (2.6%), but the rates for men and women were approximately equal (0.8%). During the period of the study, treatment prevalence increased rapidly (11.8% per year) for the population as a whole. Treatment rates grew more rapidly for adults than for children, more rapidly for women than for men, and more rapidly for girls than for boys.

Conclusion: Improved identification of ADHD in adult and female patients has contributed to rapid growth in ADHD medication use.

Citing Articles

An examination of the ocular effects of methylphenidate used in children and adolescents diagnosed with attention-deficit hyperactivity disorder.

Uzlu D, Bilginer S, Yasar Y, Tasdemir C, Erdol H, Gunay M Int Ophthalmol. 2025; 45(1):104.

PMID: 40085168 DOI: 10.1007/s10792-025-03471-z.

Increase in Occurrence of Attention Deficit Hyperactivity Disorder Differs by Age Group and Gender-Finnish Nationwide Register Study.

Westman E, Prami T, Kallio A, Iso-Mustajarvi I, Jukka J, Raittinen P Brain Behav. 2025; 15(1):e70253.

PMID: 39829159 PMC: 11743994. DOI: 10.1002/brb3.70253.

Vilazodone, a Novel SSRI Antidepressant with 5-HT1A Partial Agonist Properties: Diminished Potentiation of Chronic Oral Methylphenidate-Induced Dynorphin Expression in the Striatum in Adolescent Male Rats.

Hrabak M, Ahmed R, Soriano M, Powell A, Thanos P, Steiner H Mol Neurobiol. 2024; 62(4):4520-4532.

PMID: 39466575 DOI: 10.1007/s12035-024-04569-8.

Changes in parental attitudes toward attention-deficit/hyperactivity disorder impairment over time.

Garcia-Argibay M, Kuja-Halkola R, Lundstrom S, Lichtenstein P, Cortese S, Larsson H JCPP Adv. 2024; 4(3):e12238.

PMID: 39411482 PMC: 11472822. DOI: 10.1002/jcv2.12238.

Early childhood exposures to phthalates in association with attention-deficit/hyperactivity disorder behaviors in middle childhood and adolescence in the ReCHARGE study.

Oh J, Schweitzer J, Buckley J, Upadhyaya S, Kannan K, Herbstman J Int J Hyg Environ Health. 2024; 259:114377.

PMID: 38692176 PMC: 11567690. DOI: 10.1016/j.ijheh.2024.114377.